Adderall has recently made headlines due to concerns about shortages and supply chain issues affecting the availability of the medication. The combination drug, which includes four salts of amphetamine, is commonly prescribed to treat conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. The shortage of Adderall has raised alarms among patients who rely on the medication for managing their symptoms.
Adderall is a central nervous system stimulant that works by increasing the levels of certain neurotransmitters in the brain. It is composed of equal parts racemic amphetamine and dextroamphetamine, with a ratio of 3:1 between dextroamphetamine and levoamphetamine. This combination of amphetamines helps to improve focus, attention, and impulse control in individuals with ADHD. However, the complex manufacturing process and regulatory challenges have contributed to periodic shortages of Adderall in the market, leading to concerns about access to this essential medication for those in need.